1.
Establishment of Transgenic Goats for Human Tissue-type Plasminogen Activator with Sperm Mediated Gene Transfer Method;
利用精子载体方法研制人组织型纤溶酶原激活剂突变体转基因羊乳腺生物反应器
2.
Construction of Bacterial Artificial Chromosome Vectors Containing Human Tissue-type Plasminogen Activator Mutant Gene Specially Expressed in Mammary Gland with Red Recombination System;
利用Red系统构建人组织型纤溶酶原激活剂突变体BAC乳腺特异表达载体
3.
Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
4.
Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer
组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
5.
Evaluation of the therapeutic effect of thrombolytic therapy with rt-PA and nursing intervention in patients with acute myocardial infarction
急性心肌梗死重组组织型纤溶酶原激活剂溶栓治疗的观察及护理
6.
Therapeutic effect observation of thrombolysis with rt-PA intravenous in recurrent cerebral infarction
重组组织型纤溶酶原激活剂对再发性脑梗死静脉溶栓治疗评价
7.
Therapeutic Effect of Ultra Earlier Thrombolysis of Recombinant Tissue Plasminogen Activator in Acute Cerebral Infarction
重组组织型纤溶酶原激活剂超早期溶栓治疗急性脑梗死的疗效
8.
Thrombolytic therapy with intravenous recombinant tissue plasminogen activator for acute cerebral infarction
重组组织型纤溶酶原激活剂静脉溶栓治疗急性脑梗死19例
9.
Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;
重组非糖基化尿激酶型纤溶酶原激活剂的研究
10.
The Recombinant Human Tissue-type Plasminogen Activator in the Treatment of Deep Venous Thrombosis of the Lower Extremities
重组组织型纤溶酶原激活剂治疗下肢深静脉血栓形成的临床应用
11.
Experimental study on prevention of the peritoneal adhesion by recombinant tissue-type plasminogen activator on rats
重组组织型纤溶酶原激活剂预防大鼠腹腔粘连的实验研究
12.
Therapeutic effect evaluation of recombinant tissue plasminogen activator in hyper acute cerebral infarction
重组组织型纤溶酶原激活剂治疗急性脑梗死的疗效评价
13.
Construction of Tissue-type Plasminogen Activator Variants and Their Expression in Prokaryotic and Eukaryotic Cells;
组织型纤溶酶原激活剂（t-PA）突变体的构建及其表达研究
14.
Construction of Eukaryotic Expessing Vector of Tissue Plasminogen Activator (t-PA);
组织型纤溶酶原激活剂（t-PA）真核表达载体的构建
15.
Advances in the Study of Tissue-type Plasminogen Activator and Its Toxicity in the Central Nervous System;
组织型纤溶酶原激活剂与中枢神经系统毒性的研究进展
16.
Construction of Tissue Plasminogen Activator-annexin A5 Fusion Gene
组织型纤溶酶原激活剂—膜联蛋白A5融合基因的构建
17.
DETERMINATION OF THE PLASMINOGEN ACTIVATOR IN THE TONSIL OF CHRONIC TONSILLITIS
慢性扁桃体炎组织中的纤溶酶原激活剂测定
18.
Comparative study on intravenous rt-PA and uroninase thrombolytic strategy for acute myocardial infarction
重组组织型纤溶酶原激活剂与尿激酶静脉内溶栓治疗急性心肌梗死的比较研究